Medicure, Inc. (NASDAQ:MCUJF)

PRESS RELEASE

published on 06/24/2024 at 23:00, 1 year 5 months ago

Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property
Medicure Inc. announces asset purchase agreement with CanAm Bioresearch for acquisition of patent and intellectual property related to new chemical entities for therapeutic use

Medicure Inc. Asset Purchase Agreement CanAm Bioresearch New Chemical Entities Therapeutic Use
BRIEF

published on 05/28/2024 at 23:05, 1 year 6 months ago

Medicure Reports Financial Results for Q1 2024 and Director Election Results

Financial Results Director Election Q1 2024 Medicure
BRIEF

published on 05/28/2024 at 23:05, 1 year 6 months ago

Medicure publie ses résultats financiers pour le premier trimestre 2024 et les résultats de l'élection des administrateurs

Résultats Financiers Médicament T1 2024 Élection Du Directeur
PRESS RELEASE

published on 05/28/2024 at 23:00, 1 year 6 months ago

Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results
Medicure Inc. reports Q1 2024 financial results and director elections. Total revenue slightly up, AGGRASTAT® revenue down. Adjusted EBITDA decreased. New director appointed

Revenue Medicure Inc. Director Elections Q1 2024 Financial Results AGGRASTAT®
BRIEF

published on 04/23/2024 at 23:05, 1 year 7 months ago

Medicure reçoit la désignation Fast Track de la FDA pour le traitement MC-1 du déficit en PNPO

Medicure Inc. Désignation De Médicament Orphelin Désignation Fast Track De La FDA MC-1 Carence En PNPO
BRIEF

published on 04/23/2024 at 23:05, 1 year 7 months ago

Medicure Receives FDA Fast Track Designation for MC-1 Treatment for PNPO Deficiency

Medicure Inc. Orphan Drug Designation FDA Fast Track Designation MC-1 PNPO Deficiency
PRESS RELEASE

published on 04/23/2024 at 23:00, 1 year 7 months ago

Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
Medicure Inc. receives FDA Fast Track designation for MC-1 to treat PNPO deficiency seizures, a serious condition. Rare Pediatric Disease and Orphan Drug designations granted

Medicure Inc. Orphan Drug Designation FDA Fast Track Designation MC-1 PNPO Deficiency Seizures
BRIEF

published on 04/08/2024 at 23:05, 1 year 8 months ago

Medicure Inc. réfléchit à son exercice 2023 et à ses performances au quatrième trimestre

Résultats Financiers Médicament Industrie Pharmaceutique AGGRASTAT ZYPITAMAG
BRIEF

published on 04/08/2024 at 23:05, 1 year 8 months ago

Medicure Inc. Reflects on its 2023 Financial Year and Q4 Performance

Financial Results Pharmaceutical Industry Medicure AGGRASTAT ZYPITAMAG
PRESS RELEASE

published on 04/08/2024 at 23:00, 1 year 8 months ago

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023
Medicure Inc. reports results from operations for the quarter and year ended December 31, 2023. Net revenue, EBITDA, and financial highlights disclosed

Financial Results EBITDA Quarterly Report Medicure Inc. Revenue Analysis

Published on 12/18/2025 at 00:55, 3 hours 7 minutes ago

Molten Metals Corp. Announces Flow-Through Financing
Published on 12/18/2025 at 00:00, 4 hours 2 minutes ago

Right Season Investments Announces Name Change to FutureGen Industries Corp.
Published on 12/17/2025 at 23:15, 4 hours 47 minutes ago

Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.
Published on 12/17/2025 at 15:00, 13 hours 2 minutes ago

BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 14 hours 2 minutes ago

UniDoc Completes H3 Health Cube Installation in Italy

View all ACCESSWIRE

Published on 12/18/2025 at 01:10, 2 hours 51 minutes ago

Samsung To Unveil New AI-Connected Living Lineup at CES 2026
Published on 12/18/2025 at 00:50, 3 hours 11 minutes ago

Historic production of graphene enhanced cement successfully completed
Published on 12/17/2025 at 22:05, 5 hours 57 minutes ago

Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques
Published on 12/17/2025 at 22:05, 5 hours 57 minutes ago

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Published on 12/17/2025 at 21:22, 6 hours 40 minutes ago

EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share

View all EQS

Published on 12/17/2025 at 20:39, 7 hours 23 minutes ago

Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 7 hours 23 minutes ago

Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 8 hours 32 minutes ago

Change in the composition of the Board
Published on 12/17/2025 at 19:30, 8 hours 32 minutes ago

Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 10 hours 2 minutes ago

Outstanding Shares and Voting Rights Statement at 30 November 2025

View all LES ECHOS COMFI WIRE

News